Diligence memo · auto-generated · as of July 2, 2026

Dermamedics Llc

Dermamedics Llc looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Dermamedics Llc operates in Pharmaceuticals, based in OKLAHOMA CITY.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Dermamedics Llc has raised $2.0M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $1.0M on —.

Most recent recorded round closed around 2012-01-24.

Valuation (modeled)modeled

Provath models Dermamedics Llc at approximately $46M (range $543K–$520M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 2.42× the median modeled value of Pre-Seed Pharmaceuticals companies in 2010–2012 (71 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 505 months.

Last raise 14.4 yr ago; this sector typically re-raises about every 13 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.0× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 27% of Pharmaceuticals peers (1613 compared).

Modeled value ranks above 41% of those peers.

Closest niche peers: Dermal Life, LLC, Armgo Pharma Inc, Third Day Healing Holdings LLC, China Yongxin Pharmaceuticals Inc., Flex Biomedical, Inc..

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.